Jefferies Financial Group’s Maravai LifeSciences MRVI Stock Holding History

Jefferies Financial Group’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$106K	Hold	17,000	–	–	﹤0.01%	1532
2026 Q1	$48.1K	Hold	17,000	–	–	﹤0.01%	1648
2025 Q4	$55.3K	Hold	17,000	–	–	﹤0.01%	1753
2025 Q3	$48.8K	Hold	17,000	–	–	﹤0.01%	1390
2025 Q2	$41K	Hold	17,000	–	–	﹤0.01%	1205
2025 Q1	$37.6K	Hold	17,000	–	–	﹤0.01%	1527
2024 Q4	$92.7K	Sell	17,000 -55,693	-77%	-$358K	﹤0.01%	1463
2024 Q3	$604K	Buy	72,693 +55,693	+328%	+$481K	﹤0.01%	931
2024 Q2	$122K	Sell	17,000 -27,500	-62%	-$237K	﹤0.01%	1274
2024 Q1	$386K	Buy	44,500 +27,500	+162%	+$186K	﹤0.01%	1132
2023 Q4	$111K	Buy	17,000 +1,753	+11%	+$11.3K	﹤0.01%	1536
2023 Q3	$152K	Buy	+15,247	New	+$167K	﹤0.01%	1392

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Jefferies Financial Group's MRVI Position: Q2 2026 in Review

Jefferies Financial Group held its Maravai LifeSciences (MRVI) position steady in Q2 2026 at 17,000 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #1532.

Jefferies Financial Group first reported a position in MRVI in Q3 2023 and has held it in 12 quarters since. The position peaked at $604K in Q3 2024. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

Jefferies Financial Group held 17,000 shares of Maravai LifeSciences worth $106K as of Q2 2026.
Jefferies Financial Group left its Maravai LifeSciences share count unchanged in Q2 2026.
Maravai LifeSciences made up ﹤0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #1532 holding.
Jefferies Financial Group first reported a position in Maravai LifeSciences in Q3 2023 and has held it in 12 quarters since.
Jefferies Financial Group's Maravai LifeSciences position peaked at $604K in Q3 2024.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.